We are live on ! Find out more
SGK

Steigerwald Gordon & Koch Portfolio holdings

AUM $1.01B
1-Year Est. Return 15.33%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+15.33%
3 Year Est. Return
+59.48%
5 Year Est. Return
+77.26%
10 Year Est. Return
+288.1%
AUM
$220M
AUM Growth
+$4.66M
Cap. Flow
+$5.76M
Cap. Flow %
2.63%
Top 10 Hldgs %
33.89%
Holding
53
New
2
Increased
31
Reduced
12
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 27.93%
2 Healthcare 19.86%
3 Energy 11.14%
4 Consumer Staples 8.24%
5 Materials 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWBI icon
51
Smith & Wesson
SWBI
$659M
$207K 0.09%
16,263
LGND icon
52
Ligand Pharmaceuticals
LGND
$6.03B
-16,880
Closed -$328K
WMT icon
53
Walmart Inc
WMT
$868B
-8,010
Closed -$206K

Similar funds

Steigerwald Gordon & Koch's Q2 2015 Portfolio in Review

As of Q2 2015, Steigerwald Gordon & Koch held 53 positions worth $220M, up 2.2% from $215M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Steigerwald Gordon & Koch's Q2 2015 filing shows 2 new, 31 increased, 12 reduced and 2 closed positions. Its largest new stake was HP: 23,187 shares worth $316K. The largest sale was Elevance Health, an estimated $655K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Energy.

  • Steigerwald Gordon & Koch's largest Q2 2015 buy was HP: 23,187 shares worth $316K.
  • Steigerwald Gordon & Koch added most to APA Corp in Q2 2015, an estimated $606K increase.
  • Steigerwald Gordon & Koch's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $655K.
  • Steigerwald Gordon & Koch fully exited Ligand Pharmaceuticals in Q2 2015, selling an estimated $328K.
  • Steigerwald Gordon & Koch's ten largest holdings make up 34% of its $220M portfolio in Q2 2015.
  • Steigerwald Gordon & Koch opened 2 new positions and closed 2 in Q2 2015.
  • Steigerwald Gordon & Koch's portfolio value rose 2.2% quarter-over-quarter to $220M.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2015, filed 13 Sep 2018.